Ester Neurosciences Ltd. is a development stage biopharmaceutical company committed to the discovery and development of novel therapeutic products for the treatment of neurological disorders such as myasthenia gravis, Alzheimer’s disease, multiple sclerosis and acute stress reactions. Ester’s unique platform technology is based on the company’s breakthrough discoveries relating to cholinergic neuromodulation and its involvement in the diseased state. Ester was led by Prof. Eli Hazum, and founded in 1997. [via]
- Everything you learn in YC, in 10 minutes - March 31, 2025
- Weekly FIRGUN Newsletter – March 28 2025 - March 28, 2025
- Weekly Firgun Newsletter – March 20 2025 - March 21, 2025